Ace investor Ashish Dhawan has bought nearly 35 lakh shares of
RELIGARE
across two trading sessions, triggering a sharp reaction in the stock.
According to NSE bulk-deal data, Dhawan purchased 18 lakh shares at ₹232 each on August 28 and another 16.98 lakh shares at ₹237 each on August 31.
Following the buying, Religare shares rallied as much as 4.5% to ₹254, taking the two-session gain to nearly 9%.
How Significant Is the Buying?
Dhawan already held around 5.24% in Religare, making the fresh purchases a significant addition to his position.
His overall stock portfolio is valued at more than ₹2,500 crore, and during the June quarter he had also increased his holdings in IIFL Finance and Bluspring Enterprises.
But Religare's Q1 Was Mixed
The buying comes despite a mixed Q1 performance:
Consolidated total income: ₹2,358 crore, up 26% YoY
Consolidated loss: ₹47 crore vs ₹8 crore profit YoY
Care Health Insurance GWP: up 37%
Religare Broking PAT: ₹7.5 crore, up 65%
So while consolidated profitability remains under pressure, some of Religare's individual businesses are showing meaningful improvement.
My View
The interesting part is that a large investor is increasing exposure despite the consolidated loss.
This suggests Dhawan may be looking beyond the near-term earnings numbers and focusing on the potential of Religare's underlying businesses and longer-term restructuring.
But investors should not blindly follow an ace investor.